Financials SomnoMed Limited

Equities

SOM

AU000000SOM1

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E. Other stock markets 02:10:05 2024-04-29 am EDT			5-day change	1st Jan Change
0.215 ^AUD	+2.38%		0.00%	-57.00%

Apr. 10	Somnomed Raises AU$5.8 Million in Institutional Entitlement Offer; AU$16.8 Million Retail Component to Launch April 16	MT
Apr. 09	SomnoMed Lowers Earnings, Revenue Guidance for Fiscal 2024; to Launch AU$22.6 Million Entitlement Offer	MT

Valuation

Fiscal Period: June	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	91.07	99.31	182.9	100.1	79.04	29.26	-	-
Enterprise Value (EV) ¹	86.96	84.67	164.1	91.39	83.75	31.61	22.56	22.12
P/E ratio	-5.13 x	-67.8 x	-145 x	-21.4 x	-9.38 x	-	-	-
Yield	-	-	-	-	-	-	-	-
Capitalization / Revenue	1.55 x	1.73 x	2.92 x	1.38 x	0.95 x	0.31 x	0.28 x	0.26 x
EV / Revenue	1.48 x	1.48 x	2.62 x	1.26 x	1 x	0.34 x	0.22 x	0.2 x
EV / EBITDA	17.6 x	18 x	42.1 x	70.3 x	39.9 x	12.6 x	3.79 x	2.79 x
EV / FCF	-11,027,215 x	24,705,884 x	297,461,835 x	107,584,346 x	-	-	-	-
FCF Yield	-0%	0%	0%	0%	-	-	-	-
Price to Book	5.11 x	2.94 x	5.69 x	3.6 x	3.53 x	0.78 x	0.54 x	0.53 x
Nbr of stocks (in thousands)	62,804	82,759	82,759	82,759	82,759	136,078	-	-
Reference price ²	1.450	1.200	2.210	1.210	0.9550	0.2150	0.2150	0.2150
Announcement Date	8/20/19	8/23/20	8/23/21	8/22/22	8/30/23	-	-	-

¹AUD in Million²AUD

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	58.89	57.3	62.71	72.58	83.62	93.04	103.1	112.6
EBITDA ¹	4.945	4.7	3.9	1.3	2.1	2.5	5.945	7.94
EBIT ¹	3.496	-0.5252	-0.618	-2.941	-4.073	-3.131	-0.2492	1.64
Operating Margin	5.94%	-0.92%	-0.99%	-4.05%	-4.87%	-3.36%	-0.24%	1.46%
Earnings before Tax (EBT)	0.6072	0.747	-0.7339	-3.496	-7.045	-	-	-
Net income	-16.44	-1.119	-1.193	-4.437	-7.999	-	-	-
Net margin	-27.91%	-1.95%	-1.9%	-6.11%	-9.57%	-	-	-
EPS	-0.2828	-0.0177	-0.0152	-0.0565	-0.1018	-	-	-
Free Cash Flow	-7.886	3.427	0.5518	0.8494	-	-	-	-
FCF margin	-13.39%	5.98%	0.88%	1.17%	-	-	-	-
FCF Conversion (EBITDA)	-	72.91%	14.15%	65.34%	-	-	-	-
FCF Conversion (Net income)	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Announcement Date	8/20/19	8/23/20	8/23/21	8/22/22	8/30/23	-	-	-

¹AUD in Million²AUD

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June	2020 S1	2021 S1	2021 S2	2023 S1	2023 S2
Net sales ¹	33.26	30.82	31.88	-	43.66
EBITDA ¹	3.008	-	0.7	-	1.3
EBIT ¹	1.452	-	-1.533	-	-1.997
Operating Margin	4.37%	-	-4.81%	-	-4.57%
Earnings before Tax (EBT)	-	-	-	-	-
Net income	-	-	-	-3.745	-
Net margin	-	-	-	-	-
EPS	0.0123	0.005900	-	-0.0477	-
Dividend per Share	-	-	-	-	-
Announcement Date	2/17/20	2/22/21	8/23/21	2/22/23	8/30/23

¹AUD in Million

Estimates

Balance Sheet Analysis

Fiscal Period: June	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	-	-	-	-	4.71	2.36	-	-
Net Cash position ¹	4.1	14.6	18.8	8.75	-	-	6.7	7.14
Leverage (Debt/EBITDA)	-	-	-	-	2.244 x	0.9426 x	-	-
Free Cash Flow	-7.89	3.43	0.55	0.85	-	-	-	-
ROE (net income / shareholders' equity)	7.42%	-4.33%	-3.62%	-14.8%	-31.3%	-	-	-
ROA (Net income/ Total Assets)	-40.9%	-2.31%	-2.02%	-7.77%	-13%	-	-	-
Assets	40.22	48.42	58.93	57.13	61.31	-	-	-
Book Value Per Share ²	0.2800	0.4100	0.3900	0.3400	0.2700	0.2800	0.4000	0.4000
Cash Flow per Share ²	-0.1000	0.0800	0.0300	0.0200	-0.0500	-0.0500	0	0.0600
Capex ¹	1.34	1.76	2.15	1.01	6.4	4.96	6.19	6.3
Capex / Sales	2.27%	3.08%	3.44%	1.39%	7.65%	5.33%	6.01%	5.59%
Announcement Date	8/20/19	8/23/20	8/23/21	8/22/22	8/30/23	-	-	-

¹AUD in Million²AUD

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for SomnoMed Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.215 AUD

Average target price

0.45 AUD

Spread / Average Target

+109.30%

Consensus

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
SOMNOMED LIMITED	-57.00%	18.64M
ABBOTT LABORATORIES	-2.54%	187B
MEDTRONIC PLC	-1.85%	106B
BECTON, DICKINSON AND COMPANY	-4.26%	66.9B
DEXCOM, INC.	+1.39%	49.45B
CENCORA, INC.	+16.82%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+3.49%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+0.65%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution